newsfilter
← Latest News
GlobeNewswire·

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm

  • On June 2, 2026, the FDA issued a warning letter to Medline Inc. regarding significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals.
  • The FDA cited Medline's failure to thoroughly investigate unexplained discrepancies or batch failures, microbial contamination incidents, & inadequate cleaning practices.
  • This marks the second FDA enforcement action against Medline within two months.
  • Following the announcement, Medline stock fell $2.56 per share (7.16%) to close at $33.19 on June 2, 2026.
  • Shareholders may contact Fletcher Moore at fletcher@fmoorelaw.com to explore potential monetary damages, corporate governance reforms, reimbursement, & incentive awards.
  • All legal representation is provided on a contingency fee basis with no costs or expenses to shareholders.